Delirium

Published on 12/04/2015 by admin

Filed under Neurology

Last modified 12/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1858 times

Chapter 4 Delirium

Delirium is an acute mental status change characterized by abnormal and fluctuating attention. There is a disturbance in level of awareness and reduced ability to direct, focus, sustain, and shift attention (American Psychiatric Association, DSM-V, Proposed Revision, 2013). These difficulties additionally impair other areas of cognition. The syndrome of delirium can be a physiological consequence of a medical condition or stem from a primary neurological cause.

Delirium is by far the most common behavioral disorder in a medical-surgical setting. In general hospitals, the prevalence ranges from 11% to 33% on admission. The incidence ranges between 6% and 56% of hospitalized patients, 15% to 53% postoperatively in elderly patients, and 80% or more of intensive care unit (ICU) patients (Fong, Tulebaev, and Inouye, 2009; Michaud et al., 2007). The consequences of delirium are serious: They include prolonged hospitalizations, increased mortality, high rates of discharges to other institutions, severe impact on caregivers and spouses, and between $38 billion and $152 billion annually in direct healthcare costs in the United States (Breitbart, Gibson, and Tremblay, 2002; Fong, Tulebaev, and Inouye, 2009; Inouye et al., 1999).

Physicians have known about this disorder since antiquity. Hippocrates referred to it as phrenitis, the origin of our word frenzy. In the 1st century ad, Celsus introduced the term delirium, from the Latin for “out of furrow,” meaning derailment of the mind, and Galen observed that delirium was often due to physical diseases that affected the mind “sympathetically.” In the 19th century, Gowers recognized that these patients could be either lethargic or hyperactive. Bonhoeffer, in his classification of organic behavioral disorders, established that delirium is associated with clouding of consciousness. Finally, Engel and Romano (1959) described alpha slowing with delta and theta intrusions on electroencephalograms (EEGs) and correlated these changes with clinical severity. They noted that treating the medical cause resulted in reversal of both the clinical and EEG changes of delirium.

Despite this long history, physicians, nurses, and other clinicians often fail to diagnose delirium (Cole, 2004; Inouye et al., 2001), and up to two-thirds of delirium cases go unidentified (Inouye, 2004). Healthcare providers often miss this syndrome more from lack of recognition than misdiagnosis. The elderly in particular may have a “quieter,” more subtle presentation of delirium that may evade detection. Adding to the confusion about delirium are the many terms used to describe this disorder: acute confusional state, acute organic syndrome, acute brain failure, acute brain syndrome, acute cerebral insufficiency, exogenous psychosis, metabolic encephalopathy, organic psychosis, ICU psychosis, toxic encephalopathy, toxic psychosis, and others.

Clinicians must take care to distinguish delirium from dementia, the other common disorder of cognitive functioning. Delirium is acute in onset (usually hours to a few days) whereas dementia is chronic (usually insidious in onset and progressive). The definition of delirium must emphasize an acute behavioral decompensation with fluctuating attention, regardless of etiology or the presence of baseline cognitive deficits or dementia. Complicating this distinction is the fact that underlying dementia is a major risk factor for delirium.

Clinicians must also take care to define the terms used with delirium. Attention is the ability to focus on specific stimuli to the exclusion of others. Awareness is the ability to perceive or be conscious of events or experiences. Arousal, a basic prerequisite for attention, indicates responsiveness or excitability into action. Coma, stupor, wakefulness, and alertness are states of arousal. Consciousness, a product of arousal, means clarity of awareness of the environment. Confusion is the inability for clear and coherent thought and speech.

Clinical Characteristics

The essential elements of delirium are summarized in Boxes 4.1 and 4.2. Among the proposed American Psychiatric Association’s criteria (DSM-V Proposed Revision, 2013) for this disorder is a disturbance that develops over a short period of time; tends to fluctuate; and impairs awareness, attention, and other areas of cognition. In general, awareness, attention, and cognition fluctuate over the course of a day. Furthermore, delirious patients have disorganized thinking and an altered level of consciousness, perceptual disturbances, disturbance of the sleep/wake cycle, increased or decreased psychomotor activity, disorientation, and memory impairment. Other cognitive, behavioral, and emotional disturbances may also occur as part of the spectrum of delirium. Delirium can be summarized into the 10 clinical characteristics that follow.

Cognitive and Related Abnormalities

Other Cognitive Deficits

Disturbances occur in visuospatial abilities and in writing. Higher visual-processing deficits include difficulties in visual object recognition, environmental orientation, and organization of drawings and other constructions.

Writing disturbance may be the most sensitive language abnormality in delirium. The most salient characteristics are abnormalities in the mechanics of writing: The formation of letters and words is indistinct, and words and sentences sprawl in different directions (Fig. 4.1). There is a reluctance to write, and there are motor impairments (e.g., tremors, micrographia) and spatial disorders (e.g., misalignment, leaving insufficient space for the writing sample). Sometimes the writing shows perseverations of loops or aspects of the writing. Spelling and syntax are also disturbed, with spelling errors particularly involving consonants, small grammatical words (prepositions and conjunctions), and the last letters of words. Writing is easily disrupted in these disorders, possibly because it depends on multiple components and is the least used language function.

image

Fig. 4.1 Writing disturbances in delirium. Patients were asked to write indicated words to dictation.

(Reprinted with permission from Chédru, J., Geschwind, N., 1972. Writing disturbances in acute confusional states. Neuropsychologia 10, 343-353.)

Pathophysiology

The pathophysiology of delirium is not entirely understood, but it depends on widely distributed neurological dysfunction. Delirium is the final common pathway of many pathophysiological disturbances that reduce or alter cerebral oxidative metabolism. These metabolic changes result in diffuse impairment in multiple neuronal pathways and systems.

Several brain areas involved in attention are particularly disturbed in delirium. Dysfunction of the anterior cingulate cortex is involved in disturbances of the management of attention (Reischies et al., 2005). Other areas include the bilateral or right prefrontal cortex in attentional maintenance and executive control, the temporoparietal junction region in disengaging and shifting attention, the thalamus in engaging attention, and the upper brainstem structures in moving the focus of attention. The thalamic nuclei are uniquely positioned to screen incoming sensory information, and small lesions in the thalamus may cause delirium. In addition, there is evidence that the right hemisphere is dominant for attention. Cortical blood flow studies suggest that right hemisphere cortical areas and their limbic connections are the “attentional gate” for sensory input through feedback to the reticular nucleus of the thalamus.

Another explanation for delirium is alterations in neurotransmitters, particularly a cholinergic-dopaminergic imbalance. There is extensive evidence for a cholinergic deficit in delirium (Inouye, 2006). Anticholinergic agents can induce the clinical and EEG changes of delirium, which are reversible with the administration of cholinergic medications such as physostigmine. The beneficial effects of donepezil, rivastigmine, and galantamine—acetylcholinesterase-inhibitor medications used for Alzheimer disease—may be partly due to an activating or attention-enhancing role. Moreover, cholinergic neurons project from the pons and the basal forebrain to the cortex and make cortical neurons more responsive to other inputs. A decrease in acetylcholine results in decreased perfusion in the frontal cortex. Hypoglycemia, hypoxia, and other metabolic changes may differentially affect acetylcholine-mediated functions. Other neurotransmitters may be involved in delirium, including dopamine, serotonin, norepinephrine, γ-aminobutyric acid, glutamine, opiates, and histamine. Dopamine has an inhibitory effect on the release of acetylcholine, hence the delirium-producing effects of l-dopa and other antiparkinsonism medications (Trzepacz and van der Mast, 2002). Opiates may induce the effects by increasing dopamine and glutamate activity. Recently, polymorphisms in genes coding for a dopamine transporter and two dopamine receptors have been associated with the development of delirium (van Munster et al., 2010).

Inflammatory cytokines such as interleukins, interferon, and tumor necrosis factor alpha (TNF-α), may contribute to delirium by altering blood-brain barrier permeability and further affecting neurotransmission (Cole, 2004; Fong et al., 2009; Inouye, 2006). The combination of inflammatory mediators and dysregulation of the limbic-hypothalamic-pituitary axis may lead to exacerbation or prolongation of delirium (Maclullich et al., 2008). Finally, secretion of melatonin, a hormone integral to circadian rhythm and the sleep/wake cycle, may be abnormal in delirious patients compared to those without delirium (van Munster, de Rooij, and Korevaar, 2009).

Diagnosis

Diagnosis is a two-step process. The first step is the recognition of delirium, which requires a thorough history, a bedside mental status examination focusing on attention, and a review of established diagnostic scales or criteria for delirium. The second step is to identify the cause from a large number of potential diagnoses. Because the clinical manifestations offer few clues to the cause, crucial to the differential diagnosis are the general history, physical examination, and laboratory assessments.

The general history assesses several elements. An abrupt decline in mentation, particularly in the hospital, should be presumed to be delirium. Although patients may state that they cannot think straight or concentrate, family members or other good historians should be available to describe the patient’s behavior and medical history. The observer may have noted early symptoms of delirium such as inability to perform at a usual level, decreased awareness of complex details, insomnia, and frightening or vivid dreams. It is crucial to obtain accurate information about systemic illnesses, drug use, recent trauma, occupational and environmental exposures, malnutrition, allergies, and any preceding symptoms leading to delirium. Furthermore, the clinician should thoroughly review the patient’s medication list.

Predisposing and Precipitating Factors

The greater the number of predisposing factors, the fewer or milder are the precipitating factors needed to result in delirium (Anderson, 2005) (Box 4.3). Four factors independently predispose to delirium: vision impairments (<20/70 binocular), severity of illness, cognitive impairment, and dehydration (high ratio of blood urea to creatinine) (Inouye, 2006). Among these, cognitive impairment or dementia is worth emphasizing. Elderly patients with dementia are five times more likely to develop delirium than those without dementia (Elie et al., 1998). Patients with dementia may develop delirium after minor medication changes or other relatively insignificant precipitating factors (Inouye, 2006

Buy Membership for Neurology Category to continue reading. Learn more here